Last reviewed · How we verify
restricted opioid prescribing — Competitive Intelligence Brief
marketed
Pain Management / Public Health Policy
Small molecule
Live · refreshed every 30 min
Target snapshot
restricted opioid prescribing (restricted opioid prescribing) — Walter Reed National Military Medical Center. Restricted opioid prescribing is a clinical policy and practice guideline that limits the use of opioid medications to reduce the risk of addiction, overdose, and adverse outcomes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| restricted opioid prescribing TARGET | restricted opioid prescribing | Walter Reed National Military Medical Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- restricted opioid prescribing CI watch — RSS
- restricted opioid prescribing CI watch — Atom
- restricted opioid prescribing CI watch — JSON
- restricted opioid prescribing alone — RSS
Cite this brief
Drug Landscape (2026). restricted opioid prescribing — Competitive Intelligence Brief. https://druglandscape.com/ci/restricted-opioid-prescribing. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab